Plasma B-type Natriuretic Peptide Levels and Risk Factors for Congestive Heart Failure in a Japanese General Population
Authors:
Open Access
- 1 January 2005
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in International Heart Journal
- Vol. 46 (3) , 465-475
Abstract
This cross-sectional study was performed to establish the rationale for BNP testing for identifying subjects at high risk of congestive heart failure (CHF) in a screening setting. Plasma BNP concentrations were measured in 8,178 community-dwelling residents (mean age, 62 ± 12 years; 3,194 males). First, in order to determine age- and sex-related reference values for plasma BNP levels, subjects having factors known to influence plasma BNP levels were excluded. The remaining 3,410 subjects were eligible for the reference study. Second, to verify BNP testing for screening for subjects at high risk of CHF, the clinical characteristics of subjects showing abnormally high plasma BNP levels (≥ 97.5 percentile for each age- and sex-specific value of the reference cohort) were examined. In the reference subjects, plasma BNP levels increased with age in both genders, and were higher in women than in men. In the original cohort, age- and sex-specific reference values for high plasma BNP levels were related to the presence of major ECG abnormalities, hypertension, mildly elevated serum creatinine levels, and a history of coronary heart disease. The results of the present study indicate that individuals with high plasma BNP levels in the community have accumulating risk factors for CHF. This suggests that plasma BNP measurement may be a useful screening test for identification of individuals at high risk of CHF within a Japanese general population.Keywords
This publication has 35 references indexed in Scilit:
- Long-Term Trends in the Incidence of and Survival with Heart FailureNew England Journal of Medicine, 2002
- Prevention of heart failureJournal of Cardiac Failure, 2002
- Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?Heart, 2002
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathyJACC, 1996
- Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Heart, 1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.Heart, 1993
- Increased Human Brain Natriuretic Peptide in Congestive Heart FailureNew England Journal of Medicine, 1990